These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7627693)
1. Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent, and comprehensive. ECAT Angina Pectoris Study Group. Bolibar I; Thompson SG; von Eckardstein A; Sandkamp M; Assmann G Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1035-42. PubMed ID: 7627693 [TBL] [Abstract][Full Text] [Related]
2. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery. Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750 [TBL] [Abstract][Full Text] [Related]
3. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians. Gupta R; Vasisht S; Bahl VK; Wasir HS Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915 [TBL] [Abstract][Full Text] [Related]
4. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355 [TBL] [Abstract][Full Text] [Related]
5. Lipid abnormalities in Greek patients with coronary artery disease. Elisaf MS; Siamopoulos KC; Tselegarides TJ; Bairaktari ETh ; Goudevenos JA; Tselepis AD; Tsolas OE; Sideris DA Int J Cardiol; 1997 Apr; 59(2):177-84. PubMed ID: 9158172 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease. Hearn JA; DeMaio SJ; Roubin GS; Hammarstrom M; Sgoutas D Am J Cardiol; 1990 Nov; 66(17):1176-80. PubMed ID: 2146869 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease. Shima K; Tanaka A; Ejiri N; Maezawa H Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743 [TBL] [Abstract][Full Text] [Related]
8. The study of serum apoprotein levels as indicators for the severity of angiographically assessed coronary artery disease. Pan QX; Liu P; Wang SC; Pan JT; Sun BY; Wu XY; Saltups A Am J Clin Pathol; 1991 Apr; 95(4):597-600. PubMed ID: 2014787 [TBL] [Abstract][Full Text] [Related]
9. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Dahlen GH; Guyton JR; Attar M; Farmer JA; Kautz JA; Gotto AM Circulation; 1986 Oct; 74(4):758-65. PubMed ID: 2944670 [TBL] [Abstract][Full Text] [Related]
10. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease. Rasouli M; Kiasari AM; Mokhberi V Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Lehtinen S; Lehtimäki T; Sisto T; Salenius JP; Nikkilä M; Jokela H; Koivula T; Ebeling F; Ehnholm C Atherosclerosis; 1995 Apr; 114(1):83-91. PubMed ID: 7605379 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Hong MK; Romm PA; Reagan K; Green CE; Rackley CE Am J Cardiol; 1991 Dec; 68(17):1646-50. PubMed ID: 1746467 [TBL] [Abstract][Full Text] [Related]
13. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244 [TBL] [Abstract][Full Text] [Related]
14. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W; Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564 [TBL] [Abstract][Full Text] [Related]
15. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries]. Bukowska H Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530 [TBL] [Abstract][Full Text] [Related]
16. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins. Rasouli M; Kiasari AM Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584 [TBL] [Abstract][Full Text] [Related]
17. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population. Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412 [TBL] [Abstract][Full Text] [Related]
18. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation. Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein (a) in subjects with or without coronary artery disease: relation to clinical history and risk factors. Maranhão RC; Vinagre CG; Arie S; Guimarães JB; da-Luz P; Bellotti G; Pileggi F Braz J Med Biol Res; 1995 Apr; 28(4):439-46. PubMed ID: 8520541 [TBL] [Abstract][Full Text] [Related]